Patient | ADV-VST origin | Donor ADV response (SFCs per 106 PBMC) | VST dose (×103 viables CD3+ IFNγ+/kg) | VST dose (×103 CD4+ IFNγ+/kg) [enrichment (% of CD4)] | VST dose (×103 CD8+ IFNγ+/kg) [enrichment (% of CD8)] |
---|---|---|---|---|---|
01-01 | HSC donor | 96 | 0.39 | 0.35 [68.4] | 0.04 [7.1] |
07-03 | HSC donor | 527 | 28.10 | 26.0 [78.5] | 2.10 [15.8] |
09-04 | HSC donor | 177 | 0.25 | 0.12 [51.0] | 0.13 [45.9] |
06-05 | HSC donor | UN | 0.92 | 0.34 [47.6] | 0.58 [56.6] |
07-06 | Haplo donor (mother) | UN | 1.21 | 0.66 [15.1] | 0.55 [11.7] |
02-08 | Haplo donor (mother) | 364 | 1.10 | 0.60 [87.7] | 0.50 [76.4] |
11-10 | Haplo donor (sister) | 446 | 3.90 | 2.99 [96.0] | 0.90 [93.5] |
12-11 | Haplo donor (mother) | 370 | 9.14 | 8.13 [94.3] | 1.01 [90.6] |
08-12 | Haplo donor (mother) | 561 | 8.28 | 7.31 [84.5] | 0.98 [69.6] |
01-13 | HSC donor | 271 | 1.41 | 1.34 [81.9] | 0.08 [39.8] |
12-14 | Haplo donor (mother) | 492 | 9.38 | 7.70 [96.1] | 1.61 [88.2] |
Mean | Â | 367 | 5.83 | 5.05 [72.8] | 0.77 [54.1] |
SD | Â | 160 | 8.23 | 7.66 [25.5] | 0.65 [32.5] |